vs
CENTERSPACE（CSR）与IRONWOOD PHARMACEUTICALS INC（IRWD）财务数据对比。点击上方公司名可切换其他公司
CENTERSPACE的季度营收约是IRONWOOD PHARMACEUTICALS INC的1.4倍（$66.6M vs $47.7M），IRONWOOD PHARMACEUTICALS INC净利率更高（-4.8% vs -27.7%，领先22.9%），CENTERSPACE同比增速更快（0.3% vs -47.3%），IRONWOOD PHARMACEUTICALS INC自由现金流更多（$74.6M vs $64.3M），过去两年CENTERSPACE的营收复合增速更高（1.6% vs -20.2%）
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
Ironwood制药公司是一家上市制药企业，其前身为Microbia公司，专注于制药领域相关业务研发与运营，面向市场开发各类创新医药产品，满足未被充分满足的临床医疗需求。
CSR vs IRWD — 直观对比
营收规模更大
CSR
是对方的1.4倍
$47.7M
营收增速更快
CSR
高出47.6%
-47.3%
净利率更高
IRWD
高出22.9%
-27.7%
自由现金流更多
IRWD
多$10.3M
$64.3M
两年增速更快
CSR
近两年复合增速
-20.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $66.6M | $47.7M |
| 净利润 | $-18.4M | $-2.3M |
| 毛利率 | 96.5% | — |
| 营业利润率 | -15.9% | 14.3% |
| 净利率 | -27.7% | -4.8% |
| 营收同比 | 0.3% | -47.3% |
| 净利润同比 | -262.9% | -200.9% |
| 每股收益（稀释后） | $-1.08 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSRIRWD
| Q4 25 | $66.6M | $47.7M | ||
| Q3 25 | $71.4M | $122.1M | ||
| Q2 25 | $68.5M | $85.2M | ||
| Q1 25 | $67.1M | $41.1M | ||
| Q4 24 | $66.4M | $90.5M | ||
| Q3 24 | $65.0M | $91.6M | ||
| Q2 24 | $65.0M | $94.4M | ||
| Q1 24 | $64.5M | $74.9M |
净利润CSRIRWD
| Q4 25 | $-18.4M | $-2.3M | ||
| Q3 25 | $53.8M | $40.1M | ||
| Q2 25 | $-14.5M | $23.6M | ||
| Q1 25 | $-3.7M | $-37.4M | ||
| Q4 24 | $-5.1M | $2.3M | ||
| Q3 24 | $-1.0M | $3.6M | ||
| Q2 24 | $-1.3M | $-860.0K | ||
| Q1 24 | $-3.9M | $-4.2M |
毛利率CSRIRWD
| Q4 25 | 96.5% | — | ||
| Q3 25 | 96.5% | — | ||
| Q2 25 | 96.5% | — | ||
| Q1 25 | 96.4% | — | ||
| Q4 24 | 96.5% | — | ||
| Q3 24 | 96.6% | — | ||
| Q2 24 | 96.6% | — | ||
| Q1 24 | 96.4% | — |
营业利润率CSRIRWD
| Q4 25 | -15.9% | 14.3% | ||
| Q3 25 | — | 61.8% | ||
| Q2 25 | -9.9% | 53.2% | ||
| Q1 25 | 7.1% | -70.7% | ||
| Q4 24 | 4.3% | 34.8% | ||
| Q3 24 | 9.8% | 28.0% | ||
| Q2 24 | 11.1% | 26.5% | ||
| Q1 24 | 6.3% | 14.7% |
净利率CSRIRWD
| Q4 25 | -27.7% | -4.8% | ||
| Q3 25 | 75.3% | 32.8% | ||
| Q2 25 | -21.2% | 27.7% | ||
| Q1 25 | -5.6% | -90.9% | ||
| Q4 24 | -7.6% | 2.5% | ||
| Q3 24 | -1.6% | 4.0% | ||
| Q2 24 | -2.0% | -0.9% | ||
| Q1 24 | -6.1% | -5.6% |
每股收益（稀释后）CSRIRWD
| Q4 25 | $-1.08 | $0.01 | ||
| Q3 25 | $3.19 | $0.23 | ||
| Q2 25 | $-0.87 | $0.14 | ||
| Q1 25 | $-0.22 | $-0.23 | ||
| Q4 24 | $-0.31 | $0.03 | ||
| Q3 24 | $-0.40 | $0.02 | ||
| Q2 24 | $-0.19 | $-0.01 | ||
| Q1 24 | $-0.37 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.8M | $215.5M |
| 总债务越低越好 | $1.0B | — |
| 股东权益账面价值 | $719.2M | $-261.8M |
| 总资产 | $1.9B | $396.9M |
| 负债/权益比越低杠杆越低 | 1.42× | — |
8季度趋势，按日历期对齐
现金及短期投资CSRIRWD
| Q4 25 | $12.8M | $215.5M | ||
| Q3 25 | $12.9M | $140.4M | ||
| Q2 25 | $12.4M | $92.9M | ||
| Q1 25 | $11.9M | $108.5M | ||
| Q4 24 | $12.0M | $88.6M | ||
| Q3 24 | $14.5M | $88.2M | ||
| Q2 24 | $14.3M | $105.5M | ||
| Q1 24 | $12.7M | $121.5M |
总债务CSRIRWD
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.1B | $199.5M | ||
| Q2 25 | $1.1B | $199.3M | ||
| Q1 25 | $955.5M | $199.2M | ||
| Q4 24 | $955.4M | $199.0M | ||
| Q3 24 | $921.3M | $198.8M | ||
| Q2 24 | $931.7M | $198.6M | ||
| Q1 24 | $929.1M | $398.3M |
股东权益CSRIRWD
| Q4 25 | $719.2M | $-261.8M | ||
| Q3 25 | $748.6M | $-264.2M | ||
| Q2 25 | $710.1M | $-308.2M | ||
| Q1 25 | $636.8M | $-334.1M | ||
| Q4 24 | $752.0M | $-301.3M | ||
| Q3 24 | $672.5M | $-311.3M | ||
| Q2 24 | $680.7M | $-321.7M | ||
| Q1 24 | $688.1M | $-330.5M |
总资产CSRIRWD
| Q4 25 | $1.9B | $396.9M | ||
| Q3 25 | $2.1B | $396.1M | ||
| Q2 25 | $2.0B | $342.9M | ||
| Q1 25 | $1.9B | $327.2M | ||
| Q4 24 | $1.9B | $350.9M | ||
| Q3 24 | $1.9B | $389.5M | ||
| Q2 24 | $1.9B | $395.6M | ||
| Q1 24 | $1.9B | $438.8M |
负债/权益比CSRIRWD
| Q4 25 | 1.42× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.5M | $74.6M |
| 自由现金流经营现金流 - 资本支出 | $64.3M | $74.6M |
| 自由现金流率自由现金流/营收 | 96.5% | 156.3% |
| 资本支出强度资本支出/营收 | 51.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $125.9M | $127.0M |
8季度趋势，按日历期对齐
经营现金流CSRIRWD
| Q4 25 | $98.5M | $74.6M | ||
| Q3 25 | $35.1M | $47.6M | ||
| Q2 25 | $25.3M | $-15.1M | ||
| Q1 25 | $25.4M | $20.0M | ||
| Q4 24 | $98.2M | $15.2M | ||
| Q3 24 | $32.3M | $9.9M | ||
| Q2 24 | $22.9M | $33.5M | ||
| Q1 24 | $24.4M | $45.0M |
自由现金流CSRIRWD
| Q4 25 | $64.3M | $74.6M | ||
| Q3 25 | $25.7M | $47.6M | ||
| Q2 25 | $15.5M | $-15.1M | ||
| Q1 25 | $20.4M | $19.9M | ||
| Q4 24 | $41.6M | — | ||
| Q3 24 | $20.5M | $9.9M | ||
| Q2 24 | $9.1M | $33.4M | ||
| Q1 24 | $2.6M | $44.9M |
自由现金流率CSRIRWD
| Q4 25 | 96.5% | 156.3% | ||
| Q3 25 | 36.0% | 39.0% | ||
| Q2 25 | 22.7% | -17.7% | ||
| Q1 25 | 30.4% | 48.4% | ||
| Q4 24 | 62.6% | — | ||
| Q3 24 | 31.5% | 10.8% | ||
| Q2 24 | 14.0% | 35.4% | ||
| Q1 24 | 4.0% | 60.0% |
资本支出强度CSRIRWD
| Q4 25 | 51.3% | 0.0% | ||
| Q3 25 | 13.1% | 0.0% | ||
| Q2 25 | 14.2% | 0.0% | ||
| Q1 25 | 7.5% | 0.1% | ||
| Q4 24 | 85.3% | 0.0% | ||
| Q3 24 | 18.2% | 0.0% | ||
| Q2 24 | 21.2% | 0.1% | ||
| Q1 24 | 33.8% | 0.1% |
现金转化率CSRIRWD
| Q4 25 | — | — | ||
| Q3 25 | 0.65× | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSR
| Multi Family Residential | $57.3M | 86% |
| Other | $8.1M | 12% |
| Other Property Revenue | $1.2M | 2% |
IRWD
暂无分部数据
